BackgroundCheck.run
Search For

Enrique G Arevalo, 5386 Walnut St, Boston, MA 02108

Enrique Arevalo Phones & Addresses

86 Walnut St, Dorchester, MA 02108    617-9290674   

86 Walnut St APT 3, Dorchester, MA 02122    617-2881082   

Union City, NJ   

169 Fields Ave, Staten Island, NY 10314    718-4941433   

Walpole, MA   

Mansfield, MA   

86 Walnut St APT 3, Dorchester, MA 02122    617-3471292   

Work

Position: Service Occupations

Ranks

Licence: Montana - Active Date: 1983

Mentions for Enrique G Arevalo

Career records & work history

Lawyers & Attorneys

Enrique Arevalo Photo 1

Enrique Arevalo - Lawyer

Address:
626-7996585 (Office)
Licenses:
Montana - Active 1983

Enrique Arevalo resumes & CV records

Resumes

Enrique Arevalo Photo 37

Co-Founder And Chief Strategy Officer

Location:
Boston, MA
Industry:
Research
Work:
Spectrus
Co-Founder and Chief Strategy Officer
Momenta Pharmaceuticals Apr 2007 - Nov 2017
Principal Scientist
Northeastern University Jul 2005 - Apr 2007
Senior Research Scientist
Massachusetts General Hospital Oct 2001 - Jul 2005
Postdoc
Harvard Medical School Oct 2001 - Jul 2005
Postdoc
Education:
The City University of New York 1995 - 2001
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry, Biophysics, Philosophy
Pontificia Universidad Católica Del Perú 1987 - 1993
Bachelors, Chemistry
Colegio San Agustín De Lima 1975 - 1986
Skills:
Protein Chemistry, Mass Spectrometry, Drug Discovery, Hplc, Lc Ms, Analytical Chemistry, Lifesciences, Cell, Assay Development, Proteomics, Biomarkers, Immunoassays
Languages:
Spanish
Enrique Arevalo Photo 38

Chief Strategy Officer And Cofounder

Location:
Boston, MA
Work:
Spectrus
Chief Strategy Officer and Cofounder
Enrique Arevalo Photo 39

Enrique Arevalo

Enrique Arevalo Photo 40

Enrique Arevalo

Enrique Arevalo Photo 41

Enrique Arevalo

Enrique Arevalo Photo 42

Enrique Arevalo

Location:
United States

Publications & IP owners

Us Patents

N-Acetylhexosamine-Containing N-Glycans In Glycoprotein Products

US Patent:
2012029, Nov 22, 2012
Filed:
Mar 12, 2012
Appl. No.:
13/417895
Inventors:
Nathaniel J. Washburn - Littleton MA, US
Enrique Arevalo - Dorchester MA, US
Kevin Millea - Saugus MA, US
Carlos J. Bosques - Arlington MA, US
Jay Duffner - Shirley MA, US
Brian E. Collins - Arlington MA, US
International Classification:
G01N 33/68
G01N 27/62
G01N 21/25
G01N 30/02
G01N 24/08
G01N 33/53
G01N 21/64
G01N 27/26
US Classification:
435 71, 435 18, 436 87, 435 29
Abstract:
The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.

Analysis Of Disulfide Bonds

US Patent:
2020010, Apr 9, 2020
Filed:
Jul 8, 2019
Appl. No.:
16/505333
Inventors:
- Cambridge MA, US
John Robblee - Cambridge MA, US
Nathaniel Washburn - Cambridge MA, US
Yan Yin - Cambridge MA, US
Enrique Arevalo - Cambridge MA, US
International Classification:
C12Q 1/37
C07K 16/00
C07K 14/705
C07K 16/24
Abstract:
The present disclosure relates to methods of evaluating, identifying, and/or producing (e.g., manufacturing) pharmaceutical products (e.g., protein therapeutics). In some instances, methods herein allow highly resolved evaluation of the disulfide bond profiles of protein therapeutics.

Glycoproteins With Anti-Inflammatory Properties

US Patent:
2018030, Oct 25, 2018
Filed:
Apr 19, 2018
Appl. No.:
15/957703
Inventors:
- Cambridge MA, US
Nathaniel J. Washburn - Littleton MA, US
Enrique Arevalo - Dorchester MA, US
Carlos J. Bosques - Arlington MA, US
International Classification:
C07K 16/00
C07K 1/107
C07K 14/435
Abstract:
Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.

N-Acetylhexosamine-Containing N-Glycans In Glycoprotein Products

US Patent:
2016006, Mar 3, 2016
Filed:
Sep 9, 2015
Appl. No.:
14/848768
Inventors:
- Cambridge MA, US
Enrique Arevalo - Dorchester MA, US
Kevin Millea - Saugus MA, US
Carlos J. Bosques - Arlington MA, US
Jay Duffner - Shirley MA, US
Brian Edward Collins - Arlington MA, US
International Classification:
C12P 21/00
Abstract:
The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.

Analysis Of Disulfide Bonds

US Patent:
2015027, Oct 1, 2015
Filed:
Mar 25, 2015
Appl. No.:
14/668764
Inventors:
- Cambridge MA, US
John ROBBLEE - Cambridge MA, US
Nathaniel WASHBURN - Cambridge MA, US
Yan YIN - Cambridge MA, US
Enrique Arevalo - Dorchester MA, US
International Classification:
C12Q 1/37
C07K 14/705
C07K 16/00
Abstract:
The present disclosure relates to methods of evaluating, identifying, and/or producing (e.g., manufacturing) pharmaceutical products (e.g., protein therapeutics). In some instances, methods herein allow highly resolved evaluation of the disulfide bond profiles of protein therapeutics.

Glycoproteins With Anti-Inflammatory Properties

US Patent:
2015021, Jul 30, 2015
Filed:
Jul 25, 2013
Appl. No.:
14/416869
Inventors:
- Cambridge MA, US
Nathaniel Washburn - Littleton MA, US
Enrique Arevalo - Dorchester MA, US
Carlos J. Bosques - Arlington MA, US
Assignee:
Momenta Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07K 16/00
C07K 1/107
C07K 14/435
Abstract:
Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.